1118P Time to quality of life (QoL) deterioration in patients (pts) with mismatch repair proficient/microsatellite stable (MMRp/MSS) primary advanced or recurrent endometrial cancer (pA/rEC) and by population subgroups in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Saved in:
| Title: | 1118P Time to quality of life (QoL) deterioration in patients (pts) with mismatch repair proficient/microsatellite stable (MMRp/MSS) primary advanced or recurrent endometrial cancer (pA/rEC) and by population subgroups in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial |
|---|---|
| Authors: | Boere, I.A.1 (AUTHOR), Edelson, M.2 (AUTHOR), Hietanen, S.H.3 (AUTHOR), Gilbert, L.4 (AUTHOR), Gold, M.A.5 (AUTHOR), Sukhina, O.6 (AUTHOR), Slomovitz, B.M.7 (AUTHOR), Zavallone, L.8 (AUTHOR), Coleman, R.L.9 (AUTHOR), Lundgren, C.10 (AUTHOR), Boone, J.11 (AUTHOR), Buttin, B.12 (AUTHOR), Armstrong, A.13 (AUTHOR), Chase, D.M.14 (AUTHOR), Holloway, R.W.15 (AUTHOR), Powell, M.A.16 (AUTHOR), Shen, Q.17 (AUTHOR), Westermayer, B.18 (AUTHOR), Mirza, M.R.19 (AUTHOR), Cloven, N.20 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS744-S744. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
